SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-004262
Filing Date
2013-01-28
Accepted
2013-01-28 16:06:53
Documents
2
Period of Report
2013-01-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v333088_8-k.htm 8-K 19367
2 EMPLOYMENT AGREEMENT v333088_ex10-1.htm EX-10.1 107629
  Complete submission text file 0001144204-13-004262.txt   128567
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54365 | Film No.: 13551786
SIC: 2836 Biological Products, (No Diagnostic Substances)